articleThe Lancet OncologyJan 14, 2020GREEN OA

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

MRMichael R. MigdenNINikhil I. KhushalaniALAnne Lynn S. ChangKDKarl D. LewisCDChrysalyne D. Schmults

The University of Texas MD Anderson Cancer Center · Moffitt Cancer Center · +16 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

472
total citations
FWCI
43.32
Percentile
100%
References
28
Citations per year

Authors

22

Topics & keywords

Topics
Keywords
  • Open label
  • Basal cell
  • Dermatology
  • Phase (matter)
  • Medicine
  • Oncology
  • Internal medicine
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding